JASPER THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.12 USD | +1.19% |
|
-11.59% | +180.35% |
| 19/06 | Jasper Therapeutics, Inc. Announces Board Changes | CI |
| 14/06 | Jasper Therapeutics, Inc. Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 33Cr | - | - | - | - | - | |
| 80TCr | ||||||
| 63TCr | ||||||
| 36TCr | - | - | - | - | ||
| 33TCr | ||||||
| 30TCr |
